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Although the half-tone illustrations are
quite frequent and of good quality, there is
only one attempt at presenting graphical
data. This is unfortunate as it lends an air
of qualitative morphological interpretation
where, in fact, quantitative analysis has clear-
ly been possible, and is acknowledged in the
text.
Most of the relevant literature is well
covered, and the over-emphasis on trans-
formed rodent cell lines as models for spon-
taneous neoplasia perhaps reflects the pre-
occupation of workers in the field, and the
paucity of hard data on short-term cultures
from human tumours, rather than any
deficency of coverage by the authors.
In summary, the merit of this book lies in
its wide coverage of the field, with good
references and presented in a clear easily
read style. The clarity and brevity of the
text could have been improved by more
graphic illustration, even at the expense of
some ofthe half-tone plates. A useful book to
have, if rather costly at £36.
R. I. FRESHNEY
Early Detection of Testicular Cancer.
Eds N. E. SKAKKEBACK, J. G. BERTHELSEN
K. M. GRIGOR & J. VINFELDT (1981)
Copenhagen: Scriptor. 239 pp. 135 Danish
Kroner.
This book contains the proceedings and
discussion from an International workshop
held in Copenhagen in November 1980.
The content is wider than the title implies,
with sections on the origin and classification
of germ-cell tumours, model systems and
epidemiological and clinical aspects. These
sections are nevertheless useful reviews of
these fields.
The incidence of testicular tumours is
increasing in many countries, and although
even advanced disease may be curable by
intensive chemotherapy, early detection is
obviously desirable when many patients may
be treated by orchidectomy alone. The
crucial section is, therefore, that on screening
and testicular biopsy of testicular-cancer
risk groups. Recent advances have stemmed
from Dr Skakkeback's studies of testicular
biopsies in infertile men with no signs of
testicular tumours. Abnormal germ cells
can be recognized in these biopsies, and the
consensus opinion is that these usually
indicate in situ malignant change. Four
risk groups have been identified: the infertile
those with atrophic or undescended testis
and the contralateral testis of patients with
overt testicular tumours. This is therefore
an important contribution to the possible
early detection of testicular tumours, though
there is still disagreement over whether
orchidectomy or a watch policy should be
adopted in these patients. The final section
deals with testicular-tumour markers, both
those of established value and those under
investigation.
Although all the contributions are of a
high standard, some will be ofmore interest to
the laboratory worker than the clinician and
,ice versa. It seems unlikely that one person
would find enough ofsufficient interest to buy
the book, but it should certainly find its way
to the specialist medical library.
G. READ
Developments in Antiviral Therapy. Ed.
L. H. COLLIER & J. OXFORD (1980) London:
Academic Press. 291 pp. £18.60 net.
This book records the proceedings of a
meeting held in London in November 1979,
though not all the papers presented there are
in print. Its contents fall into two sections.
The first describes drugs acting primarily on
the herpes viruses and on RNA respiratory
viruses. The second section describes some
aspects of interferon research. The 2
sections do not really knit together, but are a
useful summary ofthe results obtained with a
number of antiviral drugs and are useful for
reference. There is little in the book about
future development, though the editors
conclude the book with a useful summary
and some prospective remarks.
D. C. BURKE
Chemotherapy of Cancer (2nd Edn).
S. K. CARTER, M. T. BAKOWSKI & K.
HELLMANN (1981) Chichester: John Wiley
& Sons. 379 pp. £9.00 net.
The differences in emphasis betweeni this
the second edition and the first edition of
this excellent chemotherapy handbook are of
great interest. As befits a young subject
4 years older, it has mellowed. Outwardly
the editions look identical, but this one has
increased in size by 29 pages and has been
extensively revised. The first 3 sections (a
general introduction, anticancer drugs and604 BOOK REVIEWS
individual tumours) have been expanded;
the 4th section on new approaches is shorter.
The introduction deals with the strategy of
cancer treatment, basic concepts of chemo-
therapy and cancer clinical trials. More
emphasis is laid upon the patient who needs
"a sensitive and understanding physician",
when and when not to treat and upon
restraint in treating the elderly aggressively.
The diagrams are clearer but the admirable
section on types of clinical trials might be
helped by more examples of each.
The utility of the second section, where
drugs are considered individually, has been
improved bythe inclusion ofpharmacokinetic
data. Ftorafer, VM-26, dibromo-mannitrol
and calusterone no longer make it but vinde-
sine and nafoxidine now do. Perhaps the
rider on p. 79, that all doses are given as for
single-agent therapy in fit patients and the
advice on when to reduce dosage should be
more prominently displayed for the unwary.
The third section on the chemotherapy of
individual tumours is now (more usefully) in
alphabetical order rather than by tumour
groups. Despite the fact that two authors are
from Europe, vitually all examples of clinical
trials are from the United States. However,
the comments are nicely balanced; in colorec-
tal cancer, combination chemotherapy "can-
not be recommended for routine therapy"
and in ovarian cancer "controlled studies do
not exist to clearly establish the superiority
of platinum combinations over single agent
therapy". The section on adjuvant chemo-
therapy is tempered by a realism which
matches the recent data.
In the final section on new approaches,
"Immunotherapy" has been ingested by
a section called "Biological Response Modi-
fiers" and other new sections include marrow
transplantation, chemosensitivity testing and
radiosensitisers.
A. HOWELL
Regulatory Functions of Interferons. Ed.
J. VILCEK, I. GRESSER, T. C. MERIGAN
(1980) New York: Academy of Sciences.
641 pp. $124.00.
This book comprises the proceedings of a
largeinternational conference (heldinOctober
1979) under the auspices of the New York
Academy of Sciences and sponsored by 30
pharmaceutical companies, the National
Institue of Allergy and Infectious Diseases
and the National Science Foundation. At
this meeting partial amino-acid sequences of
3 different interferons were disclosed for the
first time. However, much of the data
presented here has appeared elsewhere in the
literature, as specialists in the various
fields will immediately recognize. Despite
the repetition which we have relucantly come
to regard as commonplace amongst published
conferences, the book is useful, not least
because it serves as a interdisciplinary
compendium of interferon research, which is
more extensive than other specialized inter-
feron reviews which have recently become
available.
About 300 contributors have presented
data in this volume, in a total of 58 invited
papers and 38 posters. The main subject areas
covered are: regulatory effects of inter-
ferons on lymphocytes and macrophages;
interferons as lymphokines; mechanisms of
cell-growthinhibitionandanti-tumour action;
genetics of the interferon system; regulatory
effects of interferon in various cells; purifica-
tion and properties of interferons; mole-
cular mechanisms of interferon action;
anti-viral mechanisms at the cellular level;
all of which makes for extensive reading.
Data from clinical trials are specifically
excluded, though much of the information
might be considered as a rationale for such
trials. The publication is up to the usual
high quality of the New York Academy of
Sciences. There is an author index; but no
subject index; inclusion of the latter would
have added to the general usefulness of this
otherwise comprehensive book.
M. MOORE
Cancer Markers.DiagnosticandDevelop-
mental Significance. Ed. S. SELL (1980)
Chichester: John Wiley. 541 pp. £26.50 net.
In recent years the relationship between
foetal and cancer tissue has been extended to
the products of tumour cells that can be
anlaysed bybiochemicalandimmunochemical
techniques. These range from cell-surface
markers (foetal or differentiation antigens)
placental products, hormones and isoenzymes
to a multiplicity of products such as CEA,
AFP, lymphocyte markers and nucleic acids
such as tRNA. Most of these are produced in
minute amounts in the adult but in much